| Title |
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
|
|---|---|
| Published in |
Investigational New Drugs, March 2014
|
| DOI | 10.1007/s10637-014-0071-z |
| Pubmed ID | |
| Authors |
Colin D. Weekes, Muralidhar Beeram, Anthony W. Tolcher, Kyriakos P. Papadopoulos, Lia Gore, Priti Hegde, Yan Xin, Ron Yu, L. Mason Shih, Hong Xiang, Rainer K. Brachmann, Amita Patnaik |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Unknown | 69 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 29% |
| Student > Ph. D. Student | 12 | 17% |
| Student > Master | 9 | 13% |
| Student > Bachelor | 6 | 9% |
| Student > Doctoral Student | 3 | 4% |
| Other | 10 | 14% |
| Unknown | 10 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 23% |
| Immunology and Microbiology | 13 | 19% |
| Agricultural and Biological Sciences | 13 | 19% |
| Biochemistry, Genetics and Molecular Biology | 9 | 13% |
| Neuroscience | 2 | 3% |
| Other | 5 | 7% |
| Unknown | 12 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 225. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2023.
All research outputs
#172,984
of 26,017,215 outputs
Outputs from Investigational New Drugs
#2
of 1,286 outputs
Outputs of similar age
#1,383
of 239,706 outputs
Outputs of similar age from Investigational New Drugs
#1
of 12 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,286 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,706 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.